GL1X · GenesisL1 explorer

MolNFT v1 · #77723 · protein

Structure of the TOLUENE/O-xylene monooxygenase hydroxylase T201S/I276E double mutant

3RNE · Toluene O-xylene monooxygenase component: “Structure of the TOLUENE/O-xylene monooxygenase hydroxylase T201S/I276E double mutant”. X-ray diffraction, 2 ligands (FE, OH), 13 pockets (best druggability 0.77). MolNFT v1 #77723 on…

PDB
3RNE
Type
protein
Length
896 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Toluene O-xylene monooxygenase component
EC
1.14.-.-
UniProt
Q6IV66, Q6IV62, Q6IV65
Ligands
FE, OH
Pockets
13 · best druggability 0.77

Structure

x-ray diffraction · 3 distinct chains · 63% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AToluene O-xylene monooxygenase component (EC 1.14.-.-)protein49165% helix, 2% strandQ6IV66
BToluene O-xylene monooxygenase component (EC 1.14.-.-)protein32272% helix, 0% strandQ6IV62
CToluene O-xylene monooxygenase component (EC 1.14.-.-)protein8316% helix, 40% strandQ6IV65

Ligands and binding sites

  • FE · Fe (III) ion · metal · 2 copies · chains A
  • OH · Hydroxide ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11750.770.9338OH
21240.700.9025empty
31160.700.9121empty
4690.530.8623empty
5560.500.8511empty

Interfaces

2 interfaces between chains.

  • A–B · 4269 Ų buried · 69 hydrogen bonds · protein-protein
  • A–C · 1448 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 3RNE · Structure of the Toluene/o-Xylene Monooxygenase Hydroxylase T201S/I276E Double Mutant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.